Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001999371-25-001208
Filing Date
2025-02-05
Accepted
2025-02-05 15:24:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7994
  Complete submission text file 0001999371-25-001208.txt   9731
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Subject) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-45181 | Film No.: 25592909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 737 N. MICHIGAN AVENUE, SUITE 1405 CHICAGO IL 60611
Business Address 737 N. MICHIGAN AVENUE, SUITE 1405 CHICAGO IL 60611 (312) 878-0251
David Capital Partners, LLC (Filed by) CIK: 0001569725 (see all company filings)

EIN.: 452484930 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A